Clinical Trials on 耐药性增加 in China
总计572个结果
-
Xuanwu Hospital, BeijingPeking University; Beijing Tiantan Hospital; Qilu Hospital of Shandong University; Beijing Sanbo...尚未招聘
-
Yuanyuan ZhangTianjin First Central Hospital; Tianjin Union Medical Center完全的
-
Beijing Pins Medical Co., LtdPeking University First Hospital; Beijing Tiantan Hospital招聘中
-
First Affiliated Hospital Xi'an Jiaotong University尚未招聘
-
Beijing Tiantan HospitalPeking Union Medical College Hospital; Chinese PLA General Hospital; Xuanwu Hospital, Beijing; Peking...未知
-
Peking University People's HospitalPeking University Shougang Hospital完全的
-
National Institute on Drug Dependence, ChinaPeking University; Shengjing Hospital招聘中
-
Beijing Chest HospitalWest China Hospital; Wuhan Pulmonary Hospital (Wuhan Institute For Tuberculosis Control)招聘中
-
Janssen Infectious Diseases BVBA撤销耐多药结核病中国, 乌克兰, 台湾, 大韩民国, 秘鲁, 巴西, 爱沙尼亚, 拉脱维亚, 菲律宾, 俄罗斯联邦, 南非, 泰国, 火鸡, 乔治亚州, 墨西哥, 柬埔寨, 埃塞俄比亚
-
Zhinan Yin, Ph.D.Shenzhen Third People's Hospital未知
-
Guangdong Raynovent Biotech Co., Ltd完全的
-
First Affiliated Hospital of Zhejiang University招聘中
-
Peking University Third HospitalBeijing Friendship Hospital; Beijing Chao Yang Hospital邀请报名
-
Jiangsu HengRui Medicine Co., Ltd.未知Healthy Subjects, Drug-drug Interaction, Pyrotinib中国
-
Jiangsu HengRui Medicine Co., Ltd.完全的
-
Peking University People's HospitalPeking University; Northwestern University未知对 Famitinib 和 Camrelizumab 的耐药性 | 疗效和毒性的生物标志物中国
-
Nanjing First Hospital, Nanjing Medical University完全的
-
Nanjing Zenshine Pharmaceuticals招聘中